Hansa Biopharma: Decides to cut projected annual operational cost by SEK 40-50m - Redeye

Hansa Biopharma plans to restructure the organisation to optimise resource allocation and improve operational efficiency. The planned measures will reduce the current workforce by 20% and save annual costs by SEK 40-50m.

Länk till analysen i sin helhet: https://www.redeye.se/research/1112796/hansa-biopharma-decides-to-cut-projected-annual-operational-cost-by-sek-40-50m?utm_source=finwire&utm_medium=RSS